Tradestie Institutional Equity Comparison Engine

ABEO vs MGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MGN Overall Edge

MGN Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Megan Holdings Limited Ordinary Shares (MGN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ABEO counters with relative strength in Valuation. Fundamentally, ABEO trades at 18.7x Forward P/E with -186.1% operating margin (+2745.0% YoY revenue) versus MGN at N/M Forward P/E and -7.8% operating margin (-8.4% YoY). In options structure, ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against MGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABEO
ABEO 18.7x vs MGN N/M Fwd P/E
Growth & Margin Winner MGN
Op Margin -186.1% vs -7.8% ยท YoY +2745.0% vs -8.4%
Momentum & Technical Winner MGN
1Y -42.6% vs +107.7% ยท 52W Pos 9% vs 68%
Options & Structure Winner MGN
BREAKDOWN (27th %ile IV) vs UNCLASSIFIED (N/A IV)
ABEO NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.60
+7.44% 1D
Market Cap $149.2M
1M Return -41.31%
1Y Return -42.6%
Forward P/E 18.7x
Unified AI Score
44.9 / 100 HOLD
Tech 60.0 Fund 52.0 Flow 66.0 Mom 40.0
MGN NASDAQ
Megan Holdings Limited Ordinary Shares
Agricultural Prod-Livestock & Animal Specialties
$3.53
-1.94% 1D
Market Cap $58.4M
1M Return +40.64%
1Y Return +107.65%
Forward P/E N/M
Unified AI Score
45.2 / 100 HOLD
Tech 40.0 Fund 35.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABEO -42.6% MGN +107.65% Spread: +163.22 pp (MGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABEO TTM Op. Margin: -186.1% MGN TTM Op. Margin: -7.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABEO vs MGN. Trailing 12-month operating profitability (ABEO -186.1% vs MGN -7.8%) and valuation multiples (ABEO 18.7x vs MGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABEO (5) vs MGN (5)
Institutional Metric ABEO MGN Criterion Row Winner
Market Capitalization Scale $149.2M $58.4M Larger Scale ABEO
Trailing P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Forward P/E Ratio Valuation 18.7x N/M Lower Multiple ABEO
Revenue Growth (YoY) Growth +2745.0% -8.4% Higher Growth ABEO
Operating Margin (TTM) Profitability -186.1% -7.8% Higher Margin MGN
Net Profit Margin Profitability -160.3% -8.3% Higher Margin MGN
Return on Equity (ROE) Capital Efficiency -42.1% -12.6% Higher ROE MGN
52-Week Range Position Momentum 9% ($2โ€“$8) 68% ($0โ€“$5) Stronger Trend MGN
Beta / 30D Volatility Risk Regime 0.60ฮฒ ยท 149% Vol 21.11ฮฒ ยท 158% Vol Lower Realized Risk ABEO
Unified Institutional Score Composite Signal 44.9 / 100 (HOLD) 45.2 / 100 (HOLD) Higher Composite MGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABEO vs MGN Buy Guide
ABEO BREAKDOWN
67d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABEO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABEO nor MGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.